GlassScriptPhysician profile
Jason T Call
NPI 1528021862
$7,309.74
in general payments reported to CMS, 2019-2025
28 companies · $458 in 2025
The $458 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $960 · 2021: $667 · 2022: $658 · 2023: $2,974 · 2024: $1,251 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668 · Consulting Fee: $1,040 · Travel and Lodging: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.88 |
| Consulting Fee | $1,040.00 |
| Travel and Lodging | $975.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $2,193.45 | 2023 | Xiaflex |
| Medtronic, INC. | $965.62 | 2021-2024 | Corevalve Evolut R, Endurant Iis, Heli-Fx Endoanchor System |
| Abiomed | $877.75 | 2024-2025 | Impella |
| Medtronic Vascular, INC. | $846.37 | 2019-2020 | |
| Edwards Lifesciences Corporation | $380.13 | 2020-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $352.02 | 2019-2023 | Mitraclip |
| Shockwave Medical, INC | $346.84 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $304.32 | 2021-2022 | |
| Boston Scientific Corporation | $200.56 | 2019-2025 | Resonate El Icd Vr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.99 | 2020-2022 | |
| Philips North America LLC | $137.33 | 2019-2025 | Extended Holter, (Ck4) Mcot |
| Celonova Biosciences, INC. | $89.96 | 2019 | |
| Pfizer INC. | $80.86 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $62.52 | 2019-2023 | Camzyos |
| Angiodynamics, INC. | $57.75 | 2023 | Angiovac, Auryon Laser System 100-120 Vac |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $46.44 | 2019-2023 | Lutonix Drug Coated Balloon |
| Lantheus Medical Imaging, INC. | $34.71 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $34.55 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $32.64 | 2019 | |
| Amgen INC. | $18.00 | 2019 | |
| Penumbra, INC. | $16.15 | 2024 | Ruby Coil |
| Janssen Pharmaceuticals, INC | $12.65 | 2019 | |
| Avinger INC. | $11.13 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.00 | 2023 | Lifevest |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.